-
Coronavirus disease (COVID-19) and MS
Last updated: 27 March 2020 The ‘novel coronavirus’ is an infectious disease caused by a virus that had not been previously identified in humans. COVID-19 is a strain of coronavirus which began in December 2019 in Wuhan, China, and has since... read more
-
Changes in our Executive Committee
We are excited to announce the new changes to our governing Executive Committee. After 4 years of successful collaboration, Georgina Carr – former Head of Campaigns and External Relations of the UK MS Society – decided to embark on a new journey... read more
-
EMSP joins HTx
The European Multiple Sclerosis Platform joined forces to support EURORDIS and other partners of the HTx project that envisions a new generation of healthcare decision-making. The main aim of HTx is to create a framework for the Next Generation... read more
-
MS Sessions 2019 | Bucharest, Romania
[embed] This year EMSP in collaboration with Shift MS organised the 2nd volume of the MS Sessions! A festival aiming to bring together young MSers from all over Europe. More than 170 newly diagnosed young MSers gathered up in the beautiful... read more
-
Young people’s Network 2.0 Advocacy skills training: Making a change
From the 27th to the 29th of September, EMSP organised an advocacy training workshop in Luxembourg, for the Young People’s Network members. The workshop aimed to help young MSers develop the skills and acquire the knowledge to effectively run... read more
-
MS Nurse PRO launched in Portugal
On 6 December, the European Multiple Sclerosis Platform and the Portuguese MS Society launched the... read more
-
Research and innovation: 13 things people with MS expect from N2B-patch
In 2017, an innovative project called... read more
-
Innovative Drug Delivery Treatment for Multiple Sclerosis
The N2B-Patch is a project funded by the European Union, which brings together universities, research institutes, SMEs, industry and patients organisations to explore the possibility to have treatments (in MS) that bypass the Blood Brain Barrier... read more
-
MS Data Alliance in 2019
One of the main objectives of the ‘Multiple Sclerosis Data Alliance’ (MSDA) is the implementation of a minimal data set and quality standards, approved by the European Medicine Agency (EMA), in as many MS data registries and cohorts as... read more
-
Paediatric MS Workshop in Brussels
On 27 September 2019 we gathered key stakeholders - informal Caregivers, Nurses, Neurologists, MS societies, children and young people living with MS, as well as industry partners – into a workshop to strategise the development of a Consensus... read more
-
YPN Series: Daniel’s story from Scotland
By EMSP Young People’s Network member & guest author: Daniel Lafferty Daniel’s life changed forever when he got diagnosed with multiple sclerosis (MS) at age 15, but he learned how to build the momentum of change himself. Another aspiring... read more
-
EMSP at ECTRIMS 2019: 11-13 September, Stockholm, Sweden
ECTRIMS brings newest MS research to Stockholm The 35th ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) Congress is just around the corner. From 11 to 13 September 2019, ECTRIMS, the world's largest annual... read more
